SEARCH SITE

VIRGINIA LAW PORTAL

SEARCHABLE DATABASES

ACROSS SESSIONS

Developed and maintained by the Division of Legislative Automated Systems.

1999 SESSION

  • | print version

HJ 734 Study; therapeutic interchange of chemically dissimilar drugs.

Introduced by: John J. Davies III | all patrons    ...    notes | add to my profiles

SUMMARY AS PASSED: (all summaries)

Therapeutic interchange of chemically dissimilar drugs. Directs the Joint Commission on Health Care to study the issues relating to the therapeutic interchange of chemically dissimilar drugs. The Joint Commission is directed to collect data on chemically dissimilar drugs which may be interchanged therapeutically to assess the efficacy of this practice; solicit input from experts in pharmacy and chemical composition of drugs and the mechanisms by which drugs work in the human body to treat disease; conduct a literature search for studies of the use of therapeutically dissimilar drugs for the same or similar therapies; receive input from all stakeholders, including, but not limited to, physicians, pharmacists, insurance companies, health maintenance organizations, third-party pharmacy benefit managers, managed care pharmacy organizations, physicians, patients, and manufacturers; examine other states’ laws and regulations to identify possible mechanisms for regulating the practice of therapeutic interchange of chemically dissimilar drugs; conduct a comprehensive review of the related issues at the national level; take such other actions as appears necessary and appropriate to collect sufficient data and analysis of the issues; and make recommendations concerning whether the practice of therapeutic interchange of chemically dissimilar drugs should be regulated; the components of any such regulation, if recommended; definitions of relevant terms; and the appropriate body for such regulation, if recommended.


FULL TEXT

HISTORY